Washington, D.C. (August 28, 2012) – The Biotechnology Industry Organization (BIO) Livestock Biotech Summit announced its breakout sessions for the September conference, which will focus on communication; care and use of animals in research; and financing the future of food, fiber and pharmaceuticals. These breakout sessions, combined with other unique programming planned for the Summit, will look at developing global solutions through animal biotechnology.
“Agricultural biotechnology has already been identified as key in helping to meet the challenges of healing, fueling and feeding a projected 9 billion people on earth by 2050,” said David Edwards, Director of Animal Biotechnology at BIO. “These breakout sessions will identify ways to better communicate the science and benefits behind animal biotechnology to the everyday consumer, and will examine the needs, risks and strategies for financing development and commercialization of these innovative technologies. The sessions will also provide guidance on animal care and use in research as proper protection for the wellbeing of these animals is vital to continued future development of products.”
The 2012 BIO Livestock Biotech Summit takes place September 19-21, at the Crowne Plaza Downtown in Kansas City, MO. Find the complete program and speaker list online. Register today. Complimentary media registration is available.
Breakout sessions at the 2012 Livestock Biotech Summit include:
Communicating Science to Lay Audiences
Financing the Future of Food, Fiber, and Pharmaceuticals – Investment Panel
Financing the Future of Food, Fiber, and Pharmaceuticals – Economic Development Panel
Animal Care and Use in Research
Visit BIO’s Livestock Biotech Summit website for program updates and news on summit registration, events and speakers. The program slate will cover everything from the regulatory process for genetically engineered (GE) animals and public and private funding opportunities to the science and benefits of GE agricultural animals for both food and biomedical applications.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.